Quick Summary
- What: L-Tryptophan is the dietary amino acid precursor to serotonin; 5-HTP (5-hydroxytryptophan) is the intermediate downstream of rate-limiting tryptophan hydroxylase.
- Mechanism: Tryptophan requires TPH conversion; 5-HTP bypasses this step and is directly decarboxylated to serotonin.
- Who it’s for: Men with sub-clinical low mood, sleep-onset insomnia, or serotonergic depletion from stimulants.
- Differentiator: 5-HTP produces rapid serotonin rise (risk: peripheral side effects); tryptophan produces balanced rise across serotonin and other pathways.
- Natural Plus angle: Always pair 5-HTP with an AADC-peripheral inhibitor cofactor; cycle both; never combine with SSRIs.
Deep Biochemistry
Tryptophan is the rate-limited dietary amino acid that enters the serotonin pathway. Tryptophan hydroxylase (TPH1 peripheral, TPH2 central) converts it to 5-hydroxytryptophan. Aromatic amino acid decarboxylase (AADC) then converts 5-HTP to serotonin. The TPH step is rate-limiting and tightly regulated.
Supplementing L-tryptophan raises the substrate, but TPH is the bottleneck — so the increase in serotonin is modest and self-regulated. Tryptophan also feeds the kynurenine pathway (~95% of dietary tryptophan flux) which produces NAD+ precursors and kynurenic acid.
Supplementing 5-HTP bypasses TPH entirely. AADC is not rate-limiting, so 5-HTP is rapidly converted to serotonin — centrally and peripherally. This is the central problem: AADC is abundant in the gut and peripheral tissues, so oral 5-HTP creates a peripheral serotonin spike that may produce GI distress, vascular effects, and cardiac concerns with chronic use. Co-administering with a peripheral AADC inhibitor (carbidopa) resolves this, but carbidopa is prescription. Without it, chronic 5-HTP is problematic.
Tony huge laws of Biochemistry Physics Applied
This compound illustrates Law 2 of the tony huge laws of biochemistry physics — Chain Optimization. The serotonin chain is precursor → TPH → 5-HTP → AADC → serotonin → vesicular storage → release. Tryptophan pushes on the first link (substrate) — the bottleneck (TPH) naturally regulates output. 5-HTP bypasses the bottleneck — fast, but destabilizes the chain’s self-regulation. Optimizing the chain means understanding where it self-regulates and where it doesn’t. Law 2 says: optimize the whole chain, not just one link. Tryptophan + B6 + zinc + adequate iron (all TPH cofactors) is the chain-optimization approach; raw 5-HTP is the bypass-and-hope-for-the-best approach.
Natural Plus Protocol
- L-Tryptophan (preferred for chronic use): 500-1500 mg, evening, on empty stomach with a small carb.
- 5-HTP (acute/short-term only): 50-200 mg evening; avoid chronic daily dosing beyond 8 weeks.
- Cofactors: Vitamin B6 (P5P form) 25-50 mg; zinc 15 mg; iron if deficient — all TPH cofactors.
- Do NOT combine with: SSRIs, MAOIs, tramadol, MDMA. Serotonin syndrome risk is serious.
- Cycle: 5-HTP pulse only. L-tryptophan can be used continuously with cycling breaks.
Stacking Recommendations
| Stack Compound | Pathway | Why It Synergizes |
|---|---|---|
| Vitamin B6 (P5P) | TPH / AADC cofactor | Without B6, the conversion enzymes are bottlenecked. |
| L-Theanine | GABA-alpha | Different pathway; adds calm without serotonergic load. |
| Magnesium Glycinate | NMDA / GABA | Supports sleep onset alongside serotonin conversion to melatonin. |
Target Audience
Men with sleep-onset insomnia driven by serotonergic deficit. Post-stimulant rebuilders. Men with sub-clinical low mood who want a precursor approach before SSRIs. Anyone building a sleep stack.
Timeline / Results Table
| Timeframe | What to Expect |
|---|---|
| Night 1 | Easier sleep onset on tryptophan or 5-HTP. |
| Week 2 | Consistent mood lift; fewer rumination episodes. |
| Week 4 | Cycle check — if 5-HTP, switch to tryptophan or rotate off. |
| Week 8 | Long-term stability on tryptophan is superior to 5-HTP. |
Interesting Perspectives
The 1989 eosinophilia-myalgia syndrome outbreak from contaminated L-tryptophan (a manufacturing contaminant, not tryptophan itself) led to a long FDA avoidance of tryptophan. Modern pharmaceutical-grade tryptophan is safe. This history still unfairly biases some users toward 5-HTP when tryptophan is actually the better long-term choice.
Contrarian take: most biohackers reach for 5-HTP because it “works faster.” They miss that peripheral AADC conversion is the entire problem with 5-HTP — chronic use accumulates peripheral serotonin in cardiac valves (fibrosis risk) and platelets. Without a carbidopa-type peripheral AADC inhibitor, 5-HTP is not appropriate for daily indefinite use.
Emerging angle: tryptophan’s kynurenine pathway metabolites (kynurenic acid, quinolinic acid) are now recognized as neuromodulators in depression and inflammation. The old “tryptophan = serotonin” framing is obsolete — you are feeding two distinct downstream systems.
FAQ
Should I take 5-HTP or L-tryptophan?
For chronic daily use, L-tryptophan is safer. 5-HTP is useful for short-term pulses but has peripheral serotonin risks with long-term use.
How much L-tryptophan should I take?
500-1500 mg in the evening on an empty stomach with a small carb.
Can I combine with an SSRI?
No. Serotonin syndrome risk is serious. Also avoid MAOIs, tramadol, and MDMA.
What cofactors do I need?
Vitamin B6 (P5P), zinc, iron — these are all TPH conversion cofactors.
Who should use this?
Men with sleep-onset insomnia, sub-clinical low mood, or post-stimulant serotonergic depletion.
References
- Fernstrom JD. “Effects and side effects associated with the non-nutritional use of tryptophan by humans.” J Nutr, 2012.
- Turner EH, et al. “Serotonin a la carte: supplementation with the serotonin precursor 5-hydroxytryptophan.” Pharmacol Ther, 2006.
- van Hiele LJ. “l-5-Hydroxytryptophan in depression: the first substitution therapy in psychiatry?” Neuropsychobiology, 1980.
- Roth BL, et al. “Serotonin 5-HT2B receptors and valvular heart disease.” N Engl J Med, 2007.
- Schaechter JD, Wurtman RJ. “Serotonin release varies with brain tryptophan levels.” Brain Res, 1990.
Related Reading
See sleep optimization protocol, high-dose melatonin, and the recovery framework.
About tony huge
Tony Huge is a self-experimenter, biohacker, and founder of enhanced labs. He has spent over a decade researching and personally testing peptides, SARMs, anabolic compounds, nootropics, and longevity protocols. Tony’s mission is to push the boundaries of human potential through science, transparency, and direct experience. Follow his research at tonyhuge.is.